13F Pro quality score
Rank #2,678 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
HARTE HANKS INC (HHS) stock profile, AI quality score, and SEC EDGAR financial data, a Industrials sector company. 13F Pro's AI-powered ranking engine scores HHS at 23.9/100 on a composite quality score built from its SEC filings, placing it at rank #2,678 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (9.2) and balance sheet strength (20.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), HARTE HANKS INC reports quarterly revenue of $38.0M, net income of $-5.0M, an operating margin of -11.8%. Top institutional holders of HHS by reported 13-F value include BLAIR WILLIAM, WESTERLY CAPITAL MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. HHS trades on the Nasdaq exchange and files with the SEC under CIK 45919. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HHS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HARTE HANKS INC directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 45919 →